Blog
Latest articles, insights, and updates from the blog.
Low-Dose Ketamine and Alcohol: Patient Safety Guide
A safety-focused guide on the risks and clinical considerations of alcohol use during ketamine therapy, covering pharmacological interactions, metabolism, timing guidelines, and patient counseling strategies.
How to Start a Ketamine Therapy Practice: A Clinician's Guide
A comprehensive guide for clinicians on launching a ketamine therapy practice, covering DEA licensing, state regulations, clinical protocols, compounding pharmacy partnerships, liability considerations, and insurance frameworks.
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
Five anonymized clinical case studies illustrating treatment outcomes with low-dose ketamine across treatment-resistant depression, PTSD, chronic pain, and bipolar depression, with detailed dosing, timelines, and clinical lessons.
Tracking Treatment Response to Ketamine: PHQ-9, MADRS, and Clinical Scales
A clinician's guide to systematic outcome measurement in ketamine therapy, covering validated rating scales, assessment frequency, response and remission thresholds, and data-driven decision-making for dosing adjustments.
Cost and Insurance Coverage
Answers to common questions about the cost of ketamine therapy, insurance coverage options, differences between generic and branded treatments, and strategies for managing expenses.
Ketamine Dosing and Administration: A Complete Clinical Guide
A comprehensive clinical reference for ketamine dosing across all routes of administration. Covers pharmacokinetics, weight-based dosing, dose-response relationships, titration strategies, route-specific protocols, special population considerations, and monitoring requirements.
Dosing and Administration
Common questions about ketamine dosing, routes of administration, weight-based calculations, dose adjustments, and the differences between clinic and at-home treatment.
Ketamine vs TMS (Transcranial Magnetic Stimulation): Two Approaches to Treatment-Resistant Depression
Evidence-based comparison of ketamine therapy and transcranial magnetic stimulation (TMS) for treatment-resistant depression, examining mechanisms, treatment protocols, efficacy, side effects, FDA approval status, cost, and convenience.
Ketamine for Depression: A Comprehensive Evidence-Based Guide
An in-depth clinical guide examining the evidence for low-dose ketamine in the treatment of major depressive disorder and treatment-resistant depression. Covers mechanisms of action, clinical trial data, response predictors, duration of effect, maintenance strategies, and cost-benefit analysis.
Sublingual vs Oral (Swallowed) Ketamine: Absorption and Efficacy Differences
Detailed comparison of sublingual and oral (swallowed) ketamine administration routes, covering bioavailability differences, onset of action, first-pass metabolism, dosing strategies, taste considerations, and clinical outcomes.
The Complete Guide to Low-Dose Ketamine Therapy
A comprehensive, evidence-based guide covering what low-dose ketamine is, how it works, all routes of administration, what patients can expect during treatment, efficacy data across conditions, safety considerations, and how to find qualified providers.
Drug Interactions and Contraindications
Essential information about medications that may interact with ketamine therapy, who should avoid treatment, and how to safely manage concurrent medications.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.